Using novel protein antibodies on tissue microarrays (TMAs) for breast cancer prognosticationG. Thomas Budd(Cleveland Clinic), D. Hicks(Children's Medical Research Institute)Journal of Clinical OncologyJuly 15, 200410.1200/jco.2004.22.90140.9629Cited by 0SaveCiteExport RISWatch citationsRelated PapersKi67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)|Journal of Clinical Oncology|2017|411Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)|Journal for ImmunoTherapy of Cancer|2021|159